Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice
-
Published:2024-07
Issue:
Volume:252
Page:109950
-
ISSN:0028-3908
-
Container-title:Neuropharmacology
-
language:en
-
Short-container-title:Neuropharmacology
Author:
Chen PengORCID,
Wang Yulai,
Xie Jing,
Lei Jiexin,
Zhou Benhong
Reference54 articles.
1. ER stress in cardiac aging, a current view on the D-galactose model;Alejandro;Exp. Gerontol.,2022
2. The Epigenetic link between polyphenols, aging and age-related diseases;Arora;Genes,2020
3. Neuromodulatory effect of vardenafil on aluminium chloride/D-galactose induced Alzheimer's disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence;Awad;Inflammopharmacology,2023
4. Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer's disease;Ballesteros-Álvarez;Geroscience,2023
5. Activation of the miR-34a-mediated SIRT1/mTOR signaling pathway by urolithin A attenuates D-galactose- induced brain aging in mice;Chen;Neurotherapeutics,2019